Self-Improvement and Research Ethics (with Rob Wiblin)
Clearer Thinking with Spencer Greenberg
00:00
Navigating FDA Approval and Patient Autonomy
This chapter examines the FDA's role in drug approval and the necessity for clearer labeling standards. It advocates for patient autonomy, proposing that unapproved medications be accessible with adequate warnings to allow informed risk-taking. The conversation also addresses the shortcomings in side effect reporting and the impact of funding on medical research, highlighting the need for systemic improvements in these areas.
Transcript
Play full episode
